A retrospective study of more than 110,000 women ages 45 to 80 found that those taking GLP-1 receptor agonist medications ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

Scientists have uncovered dementia-like behavior in pancreas cells at risk of turning into cancer. The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Cervical cancer deaths are 49% higher for women living in poverty, a major report released on Thursday finds. Women living in ...

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a ...

Scientists 'Strongly Believe' Another Deadly Cancer Should Be Added to Alcohol's Risk List ...

A study from the University of Pennsylvania's Perelman School of Medicine found more evidence that weight loss drugs could be ...

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages ...

Dr. Colleen Scott at Mississippi State University is developing imaging dyes to help surgeons see tumors in real time and precisely remove them while preserving healthy tissue. Read more about her ...